Otsuka

Otsuka is a business conglomerate that specializes in pharmaceutical and food and beverage sectors. Read more

Tatsuo Higuchi's photo - President & CEO of Otsuka

President & CEO

Tatsuo Higuchi

CEO Approval Rating

86/100

Founded:

2008

Status:

PublicIndependent CompanyTokyo Stock Exchange4578

OTSUKA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Kobayashi Pharmaceutical is the biggest rival of Otsuka . Kobayashi Pharmaceutical was founded in 1919, and its headquarters is in Osaka, Hyōgo Prefecture. Kobayashi Pharmaceutical operates in the Pharmaceuticals industry. Kobayashi Pharmaceutical has 29,519 fewer employees than Otsuka .

Mitsubishi Tanabe Pharma has been one of Otsuka 's top competitors. Mitsubishi Tanabe Pharma is a Public company that was founded in Chuo-ku, Ōsaka Prefecture in 1933. Mitsubishi Tanabe Pharma competes in the Pharmaceuticals industry. Mitsubishi Tanabe Pharma has 26,187 fewer employees vs. Otsuka .

Pfizer is Otsuka 's #3 rival. Pfizer was founded in 1849 in New York, New York. Pfizer is in the Pharmaceuticals industry. Pfizer generates $30.7B more revenue than Otsuka .

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Alkermes a competitor of Otsuka ?

Otsuka Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$13.8B

Otsuka 's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 15.9B. Over the last three quarters, Otsuka 's revenue has grown by 19.7%. Specifically, in Q4 2020's revenue was $3.9B; in Q3 2020, it was $3.5B; in Q2 2020, it was $3.2B.

Otsuka Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Proteus Digital Health, Inc.

Aug 2020

Source »
undisclosed
Proteus develops and manufactures ingestible sensors that allows physicians and health systems to track medication usage of patients.

-

Cefixime Business of Astellas Pharma

Jun 2019

Source »
undisclosed
-
Veryan Medical, Ltd.

Dec 2018

Source »
undisclosed
Veryan designs and manufactures interventional cardiovascular medical devices.
Visterra, Inc.

Jul 2018

Source »
$430M
Visterra develops and commercializes antibody therapeutics for the treatment of pandemic influenza and chronic kidney diseases.
ReCor Medical, Inc.

Jul 2018

Source »
undisclosed
ReCor Medical develops therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension.

These are all the companies that Otsuka has acquired. Otsuka has acquired 7 companies and its latest acquisition was Proteus Digital Health, Inc. in Aug 2020. Proteus develops and manufactures ingestible sensors that allows physicians and health systems to track medication usage of patients.

Otsuka Funding History

No recent funding data found related to Otsuka

Otsuka Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

StartUp Health is a business accelerator that focuses on organizing, supporting and investing in digital health companies.
$31M
Sep 24, 2018
Equity
-
ReCor Medical develops therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension.
$12M
May 11, 2016
Debt
Jul 01, 2018
ReCor Medical develops therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension.
$15M
Apr 09, 2015
Series D
Jul 01, 2018

These are all the companies that Otsuka has invested in. Otsuka has invested 7 companies and its latest investment was Proteus Digital Health, Inc. in Aug 2020. Proteus develops and manufactures ingestible sensors that allows physicians and health systems to track medication usage of patients.

Otsuka News

April 28, 2021MarketScreener

Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation

(marketscreener.com) April 28, 2021 Company Name Otsuka Holdings Co., Ltd. ...https://www.marketscree... See more »
April 27, 2021CompanyNews HQ

Otsuka Group Company, A&P Inphatec, Commences Sales in U.S. of XylPhi-PD ,a Bactericidal Treatment for Pierce's Disease in GrapevinesNews Releases | Otsuka Pharmaceutical Co., Ltd.

April 27, 2021 Otsuka Pharmaceutical Co., Ltd. Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical... See more »
April 13, 2021MarketScreener

Decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer's-type dementia

(marketscreener.com) For Immediate Release April 13, 2021 Company name ...https://www.marketscreener.... See more »
March 30, 2021BioSpace

Otsuka and Akebia Announce Submission of New Drug Application to the FDA for Approval of Akebia's Vadadustat

Indications for renal anemia associated with chronic kidney disease in both dialysis-dependent and no... See more »
March 30, 2021MarketScreener

appoints Board Members and Audit & Supervisory Board Members (147KB)

(marketscreener.com) March 30, 2021 Otsuka Holdings appoints Board Members and Audit & Supervisory Bo... See more »
March 22, 2021CompanyNews HQ

New Drug Application for Oral Disintegrated Tablet Formulation of TAKECAB for Treatment of Acid-Related DiseaseNews Releases | Otsuka Pharmaceutical Co., Ltd.

March 22, 2021 Takeda Pharmaceutical Co., Ltd. Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals - Take... See more »

Otsuka Press Releases

August 14, 2019GlobalNewswire

Otsuka America Pharmaceutical, Inc. & Lundbeck Release The Second Edition Trends In Behavioral Health Guide

Gettysburg, Pa, Aug. 14, 2019 (GLOBE NEWSWIRE) -- New guide on the U.S. behavioral health financing a... See more »
July 26, 2019Accesswire

Premier Pharmacy Services Distributing Samsca(R) Through a Limited Specialty Pharmacy Network Selected by Otsuka America Pharmaceuticals Inc.

BALDWIN PARK, CA / ACCESSWIRE / July 26, 2019 / Since 2015, Premier Pharmacy Services has been part o... See more »
June 7, 2019PR Newswire

Taiho Oncology Announces Agreement with Otsuka to Commercialize Astex Pharmaceuticals' Drug Candidates

PRINCETON, N.J., June 7, 2019 /PRNewswire/ -- Taiho Oncology, Inc. announces that it has assumed comm... See more »
May 2, 2019Business Wire

Akebia and Otsuka Pharmaceutical Development & Commercialization Inc (OPDC) Announce Presentation of Four Posters at the NKF 2019 Spring Clinical Meetings

CAMBRIDGE, Mass. & PRINCETON, N.J.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biop... See more »
February 25, 2019PR Newswire

FDA Approves Taiho Oncology's LONSURF® (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

PRINCETON, N.J., Feb. 25, 2019 /PRNewswire/ -- Taiho Oncology, Inc. today announced that the United S... See more »
November 28, 2018PR Newswire

Otsuka And Patrick J. Kennedy Lead Policy Forum Celebrating 10th Anniversary Of Mental Health Parity And Addiction Equity Act

WASHINGTON, Nov. 28, 2018 /PRNewswire/ -- Otsuka America Pharmaceutical, Inc. (Otsuka), a global lead... See more »
November 16, 2018PR Newswire

Otsuka Pharmaceutical Development & Commercialization, Inc. Hosts Roundtable on Healthcare and Technology with U.S. Representative Bonnie Watson Coleman

WASHINGTON, Nov. 16, 2018 /PRNewswire/ -- Otsuka Pharmaceutical Development & Commercialization, Inc.... See more »

Otsuka Videos

Social Media

Otsuka Headquarters

2-9 Kanda-Tsukasamachi

Chiyoda-ku, Tōkyō Prefecture101-0048

81-3-6717-1410

Driving Directions »

Trending Companies

Otsuka Summary

ABOUT

Overview

Otsuka is a business conglomerate that specializes in pharmaceutical and food and beverage sectors. Otsuka was founded in 2008. Otsuka 's headquarters is located in Chiyoda-ku, Tōkyō Prefecture, JP 101-0048. Otsuka 's President & CEO, Tatsuo Higuchi...

CEO

Otsuka 's President & CEO, Tatsuo Higuchi, currently has an approval rating of 86%. Otsuka 's primary competitors are Kobayashi Pharmaceutical, Mitsubishi Tanabe Pharma & Pfizer.

Website

otsuka.com

Frequently Asked Questions about Otsuka

  1. When was Otsuka founded?

    Otsuka was founded in 2008
  2. Who is Otsuka 's CEO?

    Otsuka 's CEO is Tatsuo Higuchi
  3. How much revenue does Otsuka generate?

    Otsuka generates $13.8B in revenue
  4. How much funding does Otsuka have?

    Otsuka has historically raised $0 in funding
  5. Where is Otsuka 's headquarters?

    Otsuka 's headquarters is in Chiyoda-ku Tōkyō Prefecture, JP
  1. How many employees does Otsuka have?

    Otsuka has 32,992 employees
  2. What sector does Otsuka operate in?

    Otsuka is in Health Care Equipment
  3. Who are Otsuka 's competitors?

    Otsuka 's top competitors are Kobayashi Pharmaceutical, Mitsubishi Tanabe Pharma, Pfizer
  4. Who has Otsuka invested in?

    Otsuka 's has invested in companies such as StartUp Health, ReCor Medical, ReCor Medical